Corneal Epithelial Defect Market Size, Industry Analysis, Epidemiology, Pipeline Therapies And Key Companies By DelveInsight

Corneal epithelial defects

Corneal Epithelial Defect Market Insights

Some facts of Corneal Epithelial Defect Market Report

· Corneal Epithelial Defect Market size is expected to change for 7MM during the forecast period of 2018-30.

· The key driver for the surge in market size is the rise in number of incident cases.

· As per the study conducted by Wirostko et al. titled “Novel Therapy to Treat Corneal Epithelial Defects: A Hypothesis with Growth Hormone” stated that the estimated number of PCEDs per year in the United States is roughly 73,434−99,465 cases, based on a recent US population of approximately 314,037,169. The total incidence of PCEDs is less than 200,000 in the US, and is therefore considered an orphan disease in this region.

· Abdel‐Naby et al. conducted a study titled “Silk‐Derived Protein Enhances Corneal Epithelial Migration, Adhesion, and Proliferation” mentioned that annually, over 50 million people worldwide suffer from blindness as a result of corneal disease with nearly 2.5 million new eye injuries occurring each year in the United States.

· According to a study conducted by Chen et al. titled “Corneal persistent epithelial defect after pars plana vitrectomy” wherein the results showed that postoperative corneal complications developed in 103 of 460 (22.4%) eyes. Among 103 eyes with corneal complications, 21 eyes developed PCED. The eyes with PCED had poor final visual acuity, with 23.8% of the eyes in the PCED group having visual acuity of 20 per 200 or better compared with 51.2% of the eyes in the non‐PCED group.

To get more detailed insight on Corneal Epithelial Defect Market Report@Request for a Sample Report here:

View Report:

Scope of Corneal Epithelial Defect Market Report

· The report covers the descriptive overview of Corneal Epithelial Defect, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies

· Comprehensive insight has been provided into the Corneal Epithelial Defect epidemiology and treatment in the 7MM

· Additionally, an all-inclusive account of both the current and emerging therapies for Corneal Epithelial Defect are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape

· A detailed review of Corneal Epithelial Defect market; historical and forecasted is included in the report, covering drug outreach in the 7MM

· The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Corneal Epithelial Defect market

Some of Corneal Epithelial Defect Companies are:

· Noveome Biotherapeutics

· Santen Pharmaceutical

· Eyegate Pharma

· And Many Others

To get more detailed insight on Corneal Epithelial Defect Key Players@Request for a Sample Report here:

View Report:

Corneal Epithelial Defect Therapies are:

· ST266

· DE‐105

· Ocular bandage gel (OBG)

· And Many Others

To get more detailed insight about Corneal Epithelial Defect Therapies@Request for a Sample Report here:

Table of Contents:

1. Key Insights

2. Executive Summary of Corneal Epithelial Defect

3. Competitive Intelligence Analysis for Corneal Epithelial Defect

4. Corneal Epithelial Defect: Market Overview at a Glance

4.1. Corneal Epithelial Defect Total Market Share (%) Distribution in 2017

4.2. Corneal Epithelial Defect Total Market Share (%) Distribution in 2030

5. Corneal Epithelial Defect: Disease Background and Overview

6. Patient Journey

7. Corneal Epithelial Defect Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Corneal Epithelial Defect Treatment and Management

8.2. Corneal Epithelial Defect Treatment Algorithm

9. Unmet Needs

10. Key Endpoints of Corneal Epithelial Defect Treatment

11. Marketed Products

12. Emerging Therapies

13. Corneal Epithelial Defect: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Corneal Epithelial Defect

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

View Report:

Competitive Intelligence Service

Related Reports:

Thymic Carcinoma Market

Asphyxia Market

Acute Agitation And Aggression Market

HPV-Induced Cancers Market

Diagnostic Imaging Equipment Market

Epilepsy Market

Bradykinesia Market

Immunologic Deficiency Syndrome Market

Wilms Tumor Market

Advanced Wound Care Market

Defibrillators Market

Diagnostic Imaging Equipment Market

Pulse Oximeters Market

Achromatopsia Market

Cataplexy Market

Related Blogs:

Social Determinants of Health and their Impact on COVID-19

Top Drugs To Watch in HIV (2025)

Gene Therapy for Hemophilia: Progress and Setbacks

IgA Nephropathy – In-depth Assessment of the Emerging Therapies and Key Companies in the Therapeutics Domain

Smart Hospital: How it is Shaping the Future of Healthcare Delivery

An in-depth Assessment of the Top Drugs Launched by Leading Global Companies in 2021

About Delveinsight:

Market Research


Media Contact

Company Name:

Contact Person:







4.7 Star App Store Review!***uke
The Communities are great you rarely see anyone get in to an argument :)
Love Love LOVE

Select Collections